Pricing Log in Create free account
Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue
+14.5%
EPS
−43.6%
Free cash flow
+28.9%
Total debt
+140.8%

Quarter to September 2026, against a year earlier

110.08 3.52 −3.10%
Market cap
$196.6B
P/E
41.1×
Fwd P/E
35.1×
Dividend yield
2.29%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Abbott Laboratories 10-Q filed Jul 30, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed · accepted 4:14 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Apr 30, 2025: 3 added · 2 removed · 20 modified; 3 with only figures updated

  1. Modified · Financial Review — Results of Operations

    The following tables detail sales by reportable segment for the three and six months ended March 31June 30. Percent changes are versus the prior year and are based on unrounded numbers.